title: AlphaV beta3 (alphavbeta3) integrin inhibition reduces leukocyte-endothelium interaction in a pressure-induced reperfusion model.
abstract: The leukocyte-endothelium interaction is known to contribute to reperfusion injury, which is considered to participate in the pathophysiology of pressure ulcers, and integrin alphaV beta3 (alphavbeta3) has been shown to mediate the processes of cellular adhesion in various types of cells. This study aims to clarify leukocyte behavior in our original microcirculatory pressure-induced reperfusion model, which can visualize the microcirculation in vivo. We also estimated the effect of alphavbeta3 integrin inhibition on the reduction of the leukocyte-endothelium interaction. Mice with dorsal skinfold chambers were divided into three groups: the baseline group (n=6), in which animals received no compression; the compression-reperfusion group (n=6), in which animals underwent 2-hour compression of the dorsal skin, followed by release, and the inhibitor-treated group (n=7), in which an alphavbeta3 inhibitor, CP4715, was administered in addition to the compression-release procedure. Staining with rhodamine 6G quantitatively visualized leukocyte behavior under the intravital fluorescent microscope. Compression-reperfusion induced a significant increase in rolling, sticking, and extravasation of the leukocytes. Treatment with the inhibitor strikingly reduced leukocyte sticking and extravasation. The present experiment has provided evidence that alphavbeta3 inhibition reduces leukocyte-endothelium interaction in our original pressure-induced reperfusion model.
authors.affiliation: Department of Plastic and Reconstructive Surgery, Saitama Medical University, Saitama, Japan. ichioka-stm@umin.ac.jp
authors.forename: Shigeru
authors.initials: S
authors.lastname: Ichioka
authors.forename: Naomi
authors.initials: N
authors.lastname: Sekiya
authors.forename: Masahiro
authors.initials: M
authors.lastname: Shibata
authors.forename: Takashi
authors.initials: T
authors.lastname: Nakatsuka
mesh_terms: D000818:Animals; D004727:Endothelium / Q000187:drug effects* / Q000503:physiopathology; D039302:Integrin alphaVbeta3 / Q000037:antagonists & inhibitors*; D007962:Leukocytes / Q000187:drug effects* / Q000502:physiology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008833:Microcirculation / Q000187:drug effects / Q000503:physiopathology*; D008856:Microscopy, Fluorescence / Q000379:methods; D023421:Models, Animal; D010880:Piperidines / Q000494:pharmacology*; D003668:Pressure Ulcer / Q000503:physiopathology*; D011743:Pyrimidines / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000503:physiopathology*
chemical_list: C506519:CP-4715; D039302:Integrin alphaVbeta3; D010880:Piperidines; D011743:Pyrimidines